Literature DB >> 27822365

Surveillance for Cholangiocarcinoma in Patients with Primary Sclerosing Cholangitis: Effective and Justified?

Nataliya Razumilava1, Gregory J Gores2.   

Abstract

Entities:  

Keywords:  FISH; cholangiography; fluorescence in situ hybridization; liver transplantation

Year:  2016        PMID： 27822365      PMCID： PMC5096651          DOI： 10.1002/cld.567

Source DB:  PubMed          Journal:  Clin Liver Dis (Hoboken)        ISSN： 2046-2484


× No keyword cloud information.
  11 in total

1.  Diagnosis and management of primary sclerosing cholangitis.

Authors:  Roger Chapman; Johan Fevery; Anthony Kalloo; David M Nagorney; Kirsten Muri Boberg; Benjamin Shneider; Gregory J Gores
Journal:  Hepatology       Date:  2010-02       Impact factor: 17.425

2.  Natural history of small duct primary sclerosing cholangitis: a case series with review of the literature.

Authors:  A K Singal; C M Stanca; V Clark; L Dixon; C Levy; J A Odin; M I Fiel; S L Friedman; N Bach
Journal:  Hepatol Int       Date:  2011-03-11       Impact factor: 6.047

3.  Primary sclerosing cholangitis with equivocal cytology: fluorescence in situ hybridization and serum CA 19-9 predict risk of malignancy.

Authors:  Emily G Barr Fritcher; Jesse S Voss; Sarah M Jenkins; Ravi K Lingineni; Amy C Clayton; Lewis R Roberts; Kevin C Halling; Jayant A Talwalkar; Gregory J Gores; Benjamin R Kipp
Journal:  Cancer Cytopathol       Date:  2013-07-09       Impact factor: 5.284

4.  ACG Clinical Guideline: Primary Sclerosing Cholangitis.

Authors:  Keith D Lindor; Kris V Kowdley; M Edwyn Harrison
Journal:  Am J Gastroenterol       Date:  2015-04-14       Impact factor: 10.864

Review 5.  Cancer surveillance in patients with primary sclerosing cholangitis.

Authors:  Nataliya Razumilava; Gregory J Gores; Keith D Lindor
Journal:  Hepatology       Date:  2011-11       Impact factor: 17.425

Review 6.  Cholangiocarcinoma.

Authors:  Nataliya Razumilava; Gregory J Gores
Journal:  Lancet       Date:  2014-02-26       Impact factor: 79.321

7.  Trends in pre-liver transplant screening for cholangiocarcinoma among patients with primary sclerosing cholangitis.

Authors:  Panagiotis Trilianos; Florin Selaru; Zhiping Li; Ahmet Gurakar
Journal:  Digestion       Date:  2014-02-22       Impact factor: 3.216

8.  Malignancies in Primary Sclerosing Cholangitis--A Continuing Threat.

Authors:  Giulia Bonato; Laura Cristoferi; Mario Strazzabosco; Luca Fabris
Journal:  Dig Dis       Date:  2015-12-07       Impact factor: 2.404

9.  High lifetime risk of cancer in primary sclerosing cholangitis.

Authors:  Marian M H Claessen; Frank P Vleggaar; Kristien M A J Tytgat; Peter D Siersema; Henk R van Buuren
Journal:  J Hepatol       Date:  2008-10-14       Impact factor: 25.083

10.  Duration of Inflammatory Bowel Disease Is Associated With Increased Risk of Cholangiocarcinoma in Patients With Primary Sclerosing Cholangitis and IBD.

Authors:  Aliya F Gulamhusein; John E Eaton; James H Tabibian; Elizabeth J Atkinson; Brian D Juran; Konstantinos N Lazaridis
Journal:  Am J Gastroenterol       Date:  2016-03-22       Impact factor: 10.864
View more
  4 in total

1.  Primary Sclerosing Cholangitis, Part 2: Cancer Risk, Prevention, and Surveillance.

Authors:  James H Tabibian; Ahmad H Ali; Keith D Lindor
Journal:  Gastroenterol Hepatol (N Y)       Date:  2018-07

Review 2.  Challenging biliary strictures: pathophysiological features, differential diagnosis, diagnostic algorithms, and new clinically relevant biomarkers - part 1.

Authors:  Jean-Marc Dumonceau; Myriam Delhaye; Nicolas Charette; Annarita Farina
Journal:  Therap Adv Gastroenterol       Date:  2020-06-16       Impact factor: 4.409

3.  Early and accurate detection of cholangiocarcinoma in patients with primary sclerosing cholangitis by methylation markers in bile.

Authors:  Hege Marie Vedeld; Marit M Grimsrud; Kim Andresen; Heidi D Pharo; Erik von Seth; Tom H Karlsen; Hilde Honne; Vemund Paulsen; Martti A Färkkilä; Annika Bergquist; Marine Jeanmougin; Lars Aabakken; Kirsten M Boberg; Trine Folseraas; Guro E Lind
Journal:  Hepatology       Date:  2021-12-05       Impact factor: 17.298

4.  Patients with Cholangiocarcinoma Present Specific RNA Profiles in Serum and Urine Extracellular Vesicles Mirroring the Tumor Expression: Novel Liquid Biopsy Biomarkers for Disease Diagnosis.

Authors:  Ainhoa Lapitz; Ander Arbelaiz; Colm J O'Rourke; Jose L Lavin; Adelaida La Casta; Cesar Ibarra; Juan P Jimeno; Alvaro Santos-Laso; Laura Izquierdo-Sanchez; Marcin Krawczyk; Maria J Perugorria; Raul Jimenez-Aguero; Alberto Sanchez-Campos; Ioana Riaño; Esperanza Gónzalez; Frank Lammert; Marco Marzioni; Rocio I R Macias; Jose J G Marin; Tom H Karlsen; Luis Bujanda; Juan M Falcón-Pérez; Jesper B Andersen; Ana M Aransay; Pedro M Rodrigues; Jesus M Banales
Journal:  Cells       Date:  2020-03-14       Impact factor: 6.600
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.